3[2]Yamaji K,Fujimoto S,Yutani C,et al.Is the site of thrombus formation in the left atrial appendage associated with the risk of cerebral embolism? Cardiology,2002,97:104-110.
4[4]Molina CA,Montaner J,Arenillas JF,et al.Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.Stroke,2004,35:486-490.
5[5]Goldstein LB,Jones MR,Matchar DB,et al.Improving the reliability of stroke subgroup classification using the Tral of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.Stroke,2001,32:1091-1098.
6[6]Goldstein LB,Adams R,Becker K,et al.Primary prevention of ischemic stroke:A statement for healthcare professionals from the Stroke Council of the American Heart Association.Stroke,2001,32:280-299.
7[7]Bernhardt P,Schmidt H,Sommer T,et al.Atrial fibrillation-patients at high risk for cerebral embolism.Clin Res Cardiol,2006,95:148-153.
8[8]International Stroke Trial Collaborative Group.The International Stroke Trial (IST):a randomized trial of aspirin,subcutaneous heparin,both,or neither among 19345 patients with acute ischemic stroke.Lancet,1997,349:1569-1581.
9[9]Chehrazi BB,Seibert JA,Kissel P,et al.Evaluation of recombinant tissue plasminogen activator in embolic stroke.Neurosurgery,1989,24:355-360.
10[10]Gross CE,Raymond SJ,Howard DB.Delayed tissueplasminogen activator therapy in a rabbit model of thromboembolic stroke.Neurosurgery,1995,36:1172-1177.
6Yamaji K, Fujimoto S, Yutani C,et al. Is the site of thrombus forma- tion in the left atial appendage associated with the risk of cerebral embolism [ J ]. Cardiology, 2002,97 ( 2 ) : 104 - 110.
7yon Klcmperer A, Bateman K, Owen J, et al. Thrombolysis risk pre- diction: applying the SITS-SICH and SEDAN scores in South Afri- can patients[J]. Cardiovasc J Afr,2014,25(5) :224 -227.
8Lindley R1. Odds of favourable 3-month outcome following ischaemic stroke are greatest when treatment with intravenous alteplase is initia- ted up to 90 rain following event ,with no benefit seen if aheplase is given after 270 min[J]. Evid Based Med ,2011 , 16( 1 ) :22 -23.
